News & Analysis as of

Life Sciences Coronavirus/COVID-19 Centers for Disease Control and Prevention (CDC)

Alston & Bird

Health Care Week in Review: House Held a Markup of 23 Bills; Senators Announced a Proposal on Primary Care Payment Reform

Alston & Bird on

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

Hogan Lovells

COVID-19 Report for Life Sciences and Health Care Companies - March 2022

Hogan Lovells on

The COVID-19 Report is a compilation of coronavirus news, analysis, and insights from around the world to help life sciences and health care companies stay current in this challenging time. In this week's Report: FDA warns...more

Faegre Drinker Biddle & Reath LLP

COVID-19 Weekly Newsletter: Booster Shots Get FDA, CDC Greenlight

Major developments in vaccine authorizations and mandates continue in the U.S., while the surge in Europe has prompted one country to implement a lockdown — and also declare a national vaccine mandate. mRNA COVID-19...more

Faegre Drinker Biddle & Reath LLP

COVID-19 Weekly Newsletter: Vaccine Approved for Children, OSHA Vaccination Mandate

Efforts to continue to promote and expand access to COVID-19 vaccines reached major milestones this week, as the holiday season draws near. OSHA Vaccination Mandate - In early September, President Biden released a...more

Faegre Drinker Biddle & Reath LLP

COVID-19 Weekly Newsletter: Average Case Rates Drop From Delta Wave’s Heights

This week’s newsletter details the latest developments in the process of approving COVID-19 vaccines for children ages 5-11, a vaccine that produced promising clinical results, and new studies revealing insights about...more

Faegre Drinker Biddle & Reath LLP

COVID-19 Weekly Newsletter: FDA Considers COVID-19 Pill, Travel Restrictions To Be Lifted

A new submission for a Food and Drug Administration (FDA) emergency use authorization (EUA), new guidance for travelers entering the U.S. and continued studies into the efficacy of booster shots headlined this week’s...more

Womble Bond Dickinson

Post-Pandemic Impact on Life Expectancy

Womble Bond Dickinson on

Patients diagnosed with a terminal illness often ask, “How long do I have?” Whether you receive a life threatening diagnosis or not, as you grow older, you will probably make plans based on how long you expect to live....more

Hogan Lovells

COVID-19 Report for Life Sciences and Health Care Companies

Hogan Lovells on

The COVID-19 Report is a compilation of coronavirus news, analysis, and insights from around the world to help life sciences and health care companies stay current in this challenging time. In this week's Report: FDA revokes...more

Hogan Lovells

Coronavirus: The Hill and the Headlines, May 2021

Hogan Lovells on

In Washington: The Centers for Disease Control and Prevention (CDC) said it is looking to let cruise lines resume trips in the U.S. by mid-July and changing some of the rules to allow the ships to sail. A spokeswoman for...more

Hogan Lovells

Coronavirus: The Hill and the Headlines, April 2021 # 4

Hogan Lovells on

In Washington: The Consumer Financial Protection Bureau (CFPB) on Monday proposed a rule ordering debt collectors to inform tenants about their rights under a federal eviction ban if they’ve been unable to pay rent during the...more

Faegre Drinker Biddle & Reath LLP

COVID-19 Weekly Newsletter: An Annual COVID-19 Booster?

Vaccine news dominated the COVID-19 headlines this week, as the ongoing vaccine roll-out hit a snag and leaders contemplated the potential for annual COVID-19 booster shots....more

Hogan Lovells

Coronavirus: The Hill and the Headlines, April 2021 # 3

Hogan Lovells on

In Washington: An independent advisory panel for the Centers for Disease Control and Prevention (CDC) will meet again on April 23 to resume deliberating about the use of Johnson & Johnson's coronavirus vaccine, agency...more

Hogan Lovells

Coronavirus: The Hill and the Headlines, April 2021 # 2

Hogan Lovells on

In Washington: On April 13, the Centers for Disease Control (CDC) and Prevention and Federal Drug Administration (FDA) paused the production of the Johnson & Johnson vaccine after six women participants in the U.S. developed...more

Hogan Lovells

Coronavirus: The Hill and the Headlines, February 2021 # 18

Hogan Lovells on

In Washington: The Centers for Disease Control and Prevention (CDC) warned that gym users should wear masks when exercising, even if they are more than six feet apart, and gyms need to improve ventilation. A new agency report...more

Hogan Lovells

Coronavirus: The Hill and the Headlines, February 2021 # 10

Hogan Lovells on

In Washington: The Senate adjourned Friday evening after former President Trump’s defense lawyers rested their case on day four of Trump’s second impeachment trial. The defense used under three hours of their 16 allotted...more

Hogan Lovells

Coronavirus: The Hill and the Headlines, February 2021 # 4

Hogan Lovells on

In Washington: The White House is reportedly considering mailing masks directly to Americans. The plans have been discussed but no formal proposal has been delivered to Biden, a White House official told NBC News. Discussions...more

Hogan Lovells

Coronavirus: The Hill and the Headlines, January 2021 # 8

Hogan Lovells on

In Washington: The House voted 232-197 to impeach President Trump for a second time on a charge of inciting insurrection over the Jan. 6 siege on the U.S. Capitol that left five people, including a Capitol Police officer,...more

Hogan Lovells

Coronavirus: The Hill and the Headlines, January 2021 # 5

Hogan Lovells on

In Washington: The White House Coronavirus Task Force is warning that there may be a new fast-spreading U.S.A. variant of the coronavirus. "This fall/winter surge has been at nearly twice the rate of rise of cases as the...more

Hogan Lovells

Coronavirus: The Hill and the Headlines, January 2021 # 2

Hogan Lovells on

In Washington: In a statement on Monday, Food and Drug Administration (FDA) Commissioner Stephen Hahn and Peter Marks, director of the agency’s Center for Biologics Evaluation and Research, responded that it was...more

Bricker Graydon LLP

Providers should account for extra doses of COVID-19 vaccines in their vaccination plans

Bricker Graydon LLP on

Ohio has been receiving shipments of COVID-19 vaccines since the U.S. Food and Drug Administration (FDA) granted authorization for emergency use in December 2020....more

Jackson Walker

Unpacking the COVID-19 Vaccine Distribution: A Bright Spot During a Dark Winter

Jackson Walker on

In the waning days of autumn, it appeared that Texas was destined for a dark winter. As recently as December 14, 2020, the Texas Department of State Health Services (DSHS) reported over 1.3 million confirmed cases of...more

Bricker Graydon LLP

What health care providers need to know as COVID-19 vaccines arrive in Ohio

Bricker Graydon LLP on

With news that the Pfizer-BioNTech COVID-19 vaccine has been granted emergency use authorization (EUA) by the U.S. Food and Drug Administration (FDA), health care providers should be preparing for the months of distribution...more

Stotler Hayes Group, LLC

6 Things LTC Providers Need to Know About the COVID-19 Vaccine on the Cusp of Its US Approval

Stotler Hayes Group, LLC on

Since COVID-19 strong-armed its way to the forefront of the US media in March 2020, we’ve seen hundreds, even thousands of news stories, opinion pieces, and agency reports on related topics ranging from its impact on schools...more

Pullman & Comley - School Law

COVID-19 Testing and (Eventually/Hopefully) Vaccines: What Can the Schools Require?

We are now entering the dark winter of the COVID-19 crisis; at the same time, there is a light at the end of the tunnel.  In the meantime, Connecticut’s educational institutions (and employers in general) must consider how...more

Bricker Graydon LLP

Will you be ready when the COVID-19 vaccines arrive?

Bricker Graydon LLP on

‘Tis the season to be jolly! This holiday season may be merrier if the recently announced COVID-19 vaccination candidates obtain approval and/or authorization for use in preventing COVID-19 by the U.S. Food and Drug...more

38 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide